Search
for
Sort by
Research 30 of 1000+
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Safety of dermatologic medications in pregnancy and lactation
- 54675 Organizations to Assist Patients in Accessing Prescription Assistance Programs for Dermatology Medications
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
- Alopecia areata after denosumab treatment for osteoporosis
- 569 The patient perspective on psoriasis disease remission
- Neuroimaging of sleep and depression
- Contents
- Metabolic syndrome and dermatological diseases: association and treatment
- 0557 Possible Contributory and Protective Factors in Medication Associated Obstructive Sleep Apnea (OSA): Results from the US Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS)
- Psoriasis and Related Disorders
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Medications
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Diagnostic challenges in determining alopecia areata
- The skin findings of pregnant women and our treatment choices. A Turkish experience: a 5-year survey.
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market
- Hair Biology
- Drugs and Hair Loss
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Novel investigational drugs for alopecia areata and future perspectives
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Contents
- Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab